Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SHOX2
|
ENSG00000168779.15 | short stature homeobox 2 |
HOXC5
|
ENSG00000172789.3 | homeobox C5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SHOX2 | hg19_v2_chr3_-_157824292_157824334 | -0.48 | 5.5e-03 | Click! |
HOXC5 | hg19_v2_chr12_+_54426637_54426637 | -0.05 | 7.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106494587 | 8.34 |
ENST00000390597.2
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
chr2_-_89247338 | 7.70 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr14_-_106552755 | 7.40 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
chr14_-_106668095 | 7.40 |
ENST00000390606.2
|
IGHV3-20
|
immunoglobulin heavy variable 3-20 |
chr2_+_90077680 | 7.11 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr14_-_25078864 | 7.03 |
ENST00000216338.4
ENST00000557220.2 ENST00000382548.4 |
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX) |
chr14_+_22670455 | 5.87 |
ENST00000390460.1
|
TRAV26-2
|
T cell receptor alpha variable 26-2 |
chr2_-_89292422 | 5.84 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr2_-_89340242 | 5.81 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr14_+_22580233 | 5.81 |
ENST00000390454.2
|
TRAV25
|
T cell receptor alpha variable 25 |
chr2_+_90198535 | 5.70 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr2_+_90273679 | 5.42 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr2_+_90211643 | 5.40 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr2_-_89385283 | 5.39 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr2_-_90538397 | 5.34 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
chr2_+_87565634 | 5.24 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
chr15_-_20193370 | 4.97 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
chr2_+_90153696 | 4.91 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
chr2_-_89476644 | 4.79 |
ENST00000484817.1
|
IGKV2-24
|
immunoglobulin kappa variable 2-24 |
chr14_-_107049312 | 4.75 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
chr2_+_90043607 | 4.63 |
ENST00000462693.1
|
IGKV2D-24
|
immunoglobulin kappa variable 2D-24 (non-functional) |
chr2_-_89521942 | 4.53 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
chr4_+_40201954 | 4.52 |
ENST00000511121.1
|
RHOH
|
ras homolog family member H |
chr2_-_158345341 | 4.50 |
ENST00000435117.1
|
CYTIP
|
cytohesin 1 interacting protein |
chr14_-_107179265 | 4.45 |
ENST00000390634.2
|
IGHV2-70
|
immunoglobulin heavy variable 2-70 |
chr14_+_22337014 | 4.42 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
chr3_+_108541545 | 4.39 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr2_+_90248739 | 4.25 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
chr2_-_89327228 | 4.24 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr19_+_17638059 | 4.17 |
ENST00000599164.1
ENST00000449408.2 ENST00000600871.1 ENST00000599124.1 |
FAM129C
|
family with sequence similarity 129, member C |
chr2_+_90139056 | 4.12 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr1_+_81001398 | 4.10 |
ENST00000418041.1
ENST00000443104.1 |
RP5-887A10.1
|
RP5-887A10.1 |
chr2_-_89160770 | 3.97 |
ENST00000390240.2
|
IGKJ3
|
immunoglobulin kappa joining 3 |
chr14_+_22631122 | 3.91 |
ENST00000390458.3
|
TRAV29DV5
|
T cell receptor alpha variable 29/delta variable 5 (gene/pseudogene) |
chr14_+_22465771 | 3.89 |
ENST00000390445.2
|
TRAV17
|
T cell receptor alpha variable 17 |
chr2_-_89161432 | 3.87 |
ENST00000390242.2
|
IGKJ1
|
immunoglobulin kappa joining 1 |
chr13_-_46742630 | 3.68 |
ENST00000416500.1
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr2_+_90259593 | 3.57 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr17_+_67498538 | 3.55 |
ENST00000589647.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
chr5_+_57787254 | 3.53 |
ENST00000502276.1
ENST00000396776.2 ENST00000511930.1 |
GAPT
|
GRB2-binding adaptor protein, transmembrane |
chr6_-_128239749 | 3.50 |
ENST00000537166.1
|
THEMIS
|
thymocyte selection associated |
chr1_-_92952433 | 3.41 |
ENST00000294702.5
|
GFI1
|
growth factor independent 1 transcription repressor |
chr2_-_89513402 | 3.37 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr6_-_128239685 | 3.37 |
ENST00000368250.1
|
THEMIS
|
thymocyte selection associated |
chr7_-_142224280 | 3.35 |
ENST00000390367.3
|
TRBV11-1
|
T cell receptor beta variable 11-1 |
chr2_+_89952792 | 3.33 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
chr15_-_22448819 | 3.30 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr15_+_94899183 | 3.29 |
ENST00000557742.1
|
MCTP2
|
multiple C2 domains, transmembrane 2 |
chr6_+_161123270 | 3.17 |
ENST00000366924.2
ENST00000308192.9 ENST00000418964.1 |
PLG
|
plasminogen |
chr2_-_89568263 | 3.06 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
chr2_-_89417335 | 2.91 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr16_+_12059050 | 2.89 |
ENST00000396495.3
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr3_+_45927994 | 2.85 |
ENST00000357632.2
ENST00000395963.2 |
CCR9
|
chemokine (C-C motif) receptor 9 |
chr4_-_36245561 | 2.85 |
ENST00000506189.1
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr7_+_142000747 | 2.81 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
chr1_+_198607801 | 2.79 |
ENST00000367379.1
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr2_-_89161064 | 2.78 |
ENST00000390241.2
|
IGKJ2
|
immunoglobulin kappa joining 2 |
chr22_+_22730353 | 2.76 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr7_+_115862858 | 2.63 |
ENST00000393481.2
|
TES
|
testis derived transcript (3 LIM domains) |
chr6_+_26365443 | 2.62 |
ENST00000527422.1
ENST00000356386.2 ENST00000396934.3 ENST00000377708.2 ENST00000396948.1 ENST00000508906.2 |
BTN3A2
|
butyrophilin, subfamily 3, member A2 |
chr17_-_18950950 | 2.62 |
ENST00000284154.5
|
GRAP
|
GRB2-related adaptor protein |
chr11_+_35201826 | 2.59 |
ENST00000531873.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr1_+_81106951 | 2.58 |
ENST00000443565.1
|
RP5-887A10.1
|
RP5-887A10.1 |
chr20_+_30102231 | 2.57 |
ENST00000335574.5
ENST00000340852.5 ENST00000398174.3 ENST00000376127.3 ENST00000344042.5 |
HM13
|
histocompatibility (minor) 13 |
chr1_+_160709029 | 2.54 |
ENST00000444090.2
ENST00000441662.2 |
SLAMF7
|
SLAM family member 7 |
chr15_+_58430567 | 2.48 |
ENST00000536493.1
|
AQP9
|
aquaporin 9 |
chr1_-_114414316 | 2.48 |
ENST00000528414.1
ENST00000538253.1 ENST00000460620.1 ENST00000420377.2 ENST00000525799.1 ENST00000359785.5 |
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
chr15_+_96904487 | 2.46 |
ENST00000600790.1
|
AC087477.1
|
Uncharacterized protein |
chr2_+_68961934 | 2.46 |
ENST00000409202.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chrX_+_78200913 | 2.46 |
ENST00000171757.2
|
P2RY10
|
purinergic receptor P2Y, G-protein coupled, 10 |
chr9_+_95709733 | 2.45 |
ENST00000375482.3
|
FGD3
|
FYVE, RhoGEF and PH domain containing 3 |
chrX_+_78200829 | 2.44 |
ENST00000544091.1
|
P2RY10
|
purinergic receptor P2Y, G-protein coupled, 10 |
chr11_-_33913708 | 2.42 |
ENST00000257818.2
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr22_+_39966758 | 2.42 |
ENST00000407673.1
ENST00000401624.1 ENST00000404898.1 ENST00000402142.3 ENST00000336649.4 ENST00000400164.3 |
CACNA1I
|
calcium channel, voltage-dependent, T type, alpha 1I subunit |
chr4_-_39033963 | 2.39 |
ENST00000381938.3
|
TMEM156
|
transmembrane protein 156 |
chr7_-_105926058 | 2.37 |
ENST00000417537.1
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr2_+_68961905 | 2.32 |
ENST00000295381.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr11_-_104972158 | 2.32 |
ENST00000598974.1
ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1
CARD16
CARD17
|
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
chr14_-_106453155 | 2.27 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
chr14_+_22947861 | 2.27 |
ENST00000390482.1
|
TRAJ57
|
T cell receptor alpha joining 57 |
chr11_-_104827425 | 2.25 |
ENST00000393150.3
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase |
chr11_+_5712234 | 2.20 |
ENST00000414641.1
|
TRIM22
|
tripartite motif containing 22 |
chr1_-_153518270 | 2.19 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
chr1_+_160709076 | 2.19 |
ENST00000359331.4
ENST00000495334.1 |
SLAMF7
|
SLAM family member 7 |
chr1_+_117297007 | 2.17 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
chr1_+_160709055 | 2.13 |
ENST00000368043.3
ENST00000368042.3 ENST00000458602.2 ENST00000458104.2 |
SLAMF7
|
SLAM family member 7 |
chr6_+_167525277 | 2.12 |
ENST00000400926.2
|
CCR6
|
chemokine (C-C motif) receptor 6 |
chr14_+_22433675 | 2.11 |
ENST00000390442.3
|
TRAV12-3
|
T cell receptor alpha variable 12-3 |
chr1_+_66820058 | 2.10 |
ENST00000480109.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr11_-_13517565 | 2.08 |
ENST00000282091.1
ENST00000529816.1 |
PTH
|
parathyroid hormone |
chr4_-_48116540 | 2.08 |
ENST00000506073.1
|
TXK
|
TXK tyrosine kinase |
chr7_-_139763521 | 2.07 |
ENST00000263549.3
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12 |
chr7_-_36764142 | 2.07 |
ENST00000258749.5
ENST00000535891.1 |
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
chr3_-_151047327 | 2.06 |
ENST00000325602.5
|
P2RY13
|
purinergic receptor P2Y, G-protein coupled, 13 |
chr9_-_117111222 | 2.05 |
ENST00000374079.4
|
AKNA
|
AT-hook transcription factor |
chrX_+_37639302 | 2.03 |
ENST00000545017.1
ENST00000536160.1 |
CYBB
|
cytochrome b-245, beta polypeptide |
chr18_-_74839891 | 2.02 |
ENST00000581878.1
|
MBP
|
myelin basic protein |
chr6_+_130339710 | 2.01 |
ENST00000526087.1
ENST00000533560.1 ENST00000361794.2 |
L3MBTL3
|
l(3)mbt-like 3 (Drosophila) |
chr2_+_68962014 | 1.99 |
ENST00000467265.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr12_-_10022735 | 1.96 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
chr22_+_23222886 | 1.95 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr7_+_142378566 | 1.94 |
ENST00000390398.3
|
TRBV25-1
|
T cell receptor beta variable 25-1 |
chr22_+_40297079 | 1.92 |
ENST00000344138.4
ENST00000543252.1 |
GRAP2
|
GRB2-related adaptor protein 2 |
chr2_+_89901292 | 1.92 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr3_+_186692745 | 1.91 |
ENST00000438590.1
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
chr4_-_74486109 | 1.90 |
ENST00000395777.2
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr7_-_36764062 | 1.85 |
ENST00000435386.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
chr6_-_133035185 | 1.85 |
ENST00000367928.4
|
VNN1
|
vanin 1 |
chr1_-_157670647 | 1.85 |
ENST00000368184.3
|
FCRL3
|
Fc receptor-like 3 |
chr1_-_160681593 | 1.85 |
ENST00000368045.3
ENST00000368046.3 |
CD48
|
CD48 molecule |
chrX_-_21676442 | 1.83 |
ENST00000379499.2
|
KLHL34
|
kelch-like family member 34 |
chr11_-_104905840 | 1.82 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
chr2_-_225811747 | 1.80 |
ENST00000409592.3
|
DOCK10
|
dedicator of cytokinesis 10 |
chr11_-_104916034 | 1.80 |
ENST00000528513.1
ENST00000375706.2 ENST00000375704.3 |
CARD16
|
caspase recruitment domain family, member 16 |
chr5_+_35852797 | 1.78 |
ENST00000508941.1
|
IL7R
|
interleukin 7 receptor |
chr2_-_158345462 | 1.78 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
chr14_-_106926724 | 1.77 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
chr11_+_122733011 | 1.77 |
ENST00000533709.1
|
CRTAM
|
cytotoxic and regulatory T cell molecule |
chr22_+_50981079 | 1.76 |
ENST00000609268.1
|
CTA-384D8.34
|
CTA-384D8.34 |
chr3_+_108541608 | 1.76 |
ENST00000426646.1
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr5_-_55412774 | 1.76 |
ENST00000434982.2
|
ANKRD55
|
ankyrin repeat domain 55 |
chr1_-_36948879 | 1.76 |
ENST00000373106.1
ENST00000373104.1 ENST00000373103.1 |
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr3_-_191000172 | 1.75 |
ENST00000427544.2
|
UTS2B
|
urotensin 2B |
chr22_+_22453093 | 1.74 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr11_-_118213455 | 1.71 |
ENST00000300692.4
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
chr16_+_32077386 | 1.71 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr2_-_89278535 | 1.71 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr2_+_88047606 | 1.70 |
ENST00000359481.4
|
PLGLB2
|
plasminogen-like B2 |
chr11_+_5775923 | 1.70 |
ENST00000317254.3
|
OR52N4
|
olfactory receptor, family 52, subfamily N, member 4 (gene/pseudogene) |
chr14_-_106573756 | 1.69 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
chr14_-_106816253 | 1.69 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
chr1_-_217804377 | 1.68 |
ENST00000366935.3
ENST00000366934.3 |
GPATCH2
|
G patch domain containing 2 |
chr1_+_158801095 | 1.68 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chr2_-_87248975 | 1.68 |
ENST00000409310.2
ENST00000355705.3 |
PLGLB1
|
plasminogen-like B1 |
chr20_-_33735070 | 1.64 |
ENST00000374491.3
ENST00000542871.1 ENST00000374492.3 |
EDEM2
|
ER degradation enhancer, mannosidase alpha-like 2 |
chr4_+_56815102 | 1.64 |
ENST00000257287.4
|
CEP135
|
centrosomal protein 135kDa |
chr7_-_142181009 | 1.63 |
ENST00000390368.2
|
TRBV6-5
|
T cell receptor beta variable 6-5 |
chr2_-_89597542 | 1.63 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
chr7_+_142498725 | 1.62 |
ENST00000466254.1
|
TRBC2
|
T cell receptor beta constant 2 |
chr22_+_23134974 | 1.62 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr4_-_119759795 | 1.61 |
ENST00000419654.2
|
SEC24D
|
SEC24 family member D |
chr2_+_90108504 | 1.59 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr11_-_104817919 | 1.58 |
ENST00000533252.1
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase |
chr3_-_112564797 | 1.58 |
ENST00000398214.1
ENST00000448932.1 |
CD200R1L
|
CD200 receptor 1-like |
chr14_+_22689792 | 1.57 |
ENST00000390462.1
|
TRAV35
|
T cell receptor alpha variable 35 |
chr2_-_228244013 | 1.56 |
ENST00000304568.3
|
TM4SF20
|
transmembrane 4 L six family member 20 |
chr7_+_142031986 | 1.55 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
chr4_-_69434245 | 1.53 |
ENST00000317746.2
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17 |
chr12_-_10605929 | 1.53 |
ENST00000347831.5
ENST00000359151.3 |
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1 |
chr21_+_43823983 | 1.52 |
ENST00000291535.6
ENST00000450356.1 ENST00000319294.6 ENST00000398367.1 |
UBASH3A
|
ubiquitin associated and SH3 domain containing A |
chr18_-_67624412 | 1.52 |
ENST00000580335.1
|
CD226
|
CD226 molecule |
chr4_+_155484155 | 1.51 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
chr2_-_89310012 | 1.51 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr11_+_5710919 | 1.51 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr7_-_142120321 | 1.50 |
ENST00000390377.1
|
TRBV7-7
|
T cell receptor beta variable 7-7 |
chr4_+_71091786 | 1.49 |
ENST00000317987.5
|
FDCSP
|
follicular dendritic cell secreted protein |
chr14_+_22675388 | 1.48 |
ENST00000390461.2
|
TRAV34
|
T cell receptor alpha variable 34 |
chr15_+_58430368 | 1.46 |
ENST00000558772.1
ENST00000219919.4 |
AQP9
|
aquaporin 9 |
chr19_-_51920952 | 1.46 |
ENST00000356298.5
ENST00000339313.5 ENST00000529627.1 ENST00000439889.2 ENST00000353836.5 ENST00000432469.2 |
SIGLEC10
|
sialic acid binding Ig-like lectin 10 |
chr4_+_90800656 | 1.46 |
ENST00000394980.1
|
MMRN1
|
multimerin 1 |
chr7_+_142353445 | 1.46 |
ENST00000390396.1
|
TRBV23-1
|
T cell receptor beta variable 23-1 (non-functional) |
chr22_+_23101182 | 1.45 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr15_+_81589254 | 1.44 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
chr6_-_26235206 | 1.44 |
ENST00000244534.5
|
HIST1H1D
|
histone cluster 1, H1d |
chr19_+_50016610 | 1.44 |
ENST00000596975.1
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
chr14_+_23002427 | 1.43 |
ENST00000390527.1
|
TRAJ10
|
T cell receptor alpha joining 10 |
chr22_+_23154239 | 1.42 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
chr12_+_8666126 | 1.42 |
ENST00000299665.2
|
CLEC4D
|
C-type lectin domain family 4, member D |
chr14_-_106471723 | 1.42 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
chr17_-_3595181 | 1.41 |
ENST00000552050.1
|
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr14_+_22931924 | 1.41 |
ENST00000390477.2
|
TRDC
|
T cell receptor delta constant |
chr5_-_70316737 | 1.41 |
ENST00000194097.4
|
NAIP
|
NLR family, apoptosis inhibitory protein |
chr13_+_32313658 | 1.40 |
ENST00000380314.1
ENST00000298386.2 |
RXFP2
|
relaxin/insulin-like family peptide receptor 2 |
chr4_+_155484103 | 1.40 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
chr4_-_71532207 | 1.37 |
ENST00000543780.1
ENST00000391614.3 |
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr4_-_74486217 | 1.37 |
ENST00000335049.5
ENST00000307439.5 |
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr1_-_150738261 | 1.37 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr5_-_119669160 | 1.36 |
ENST00000514240.1
|
CTC-552D5.1
|
CTC-552D5.1 |
chr3_-_3151664 | 1.36 |
ENST00000256452.3
ENST00000311981.8 ENST00000430514.2 ENST00000456302.1 |
IL5RA
|
interleukin 5 receptor, alpha |
chr14_+_22392209 | 1.35 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
chr12_-_10601963 | 1.35 |
ENST00000543893.1
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1 |
chr6_+_139456226 | 1.35 |
ENST00000367658.2
|
HECA
|
headcase homolog (Drosophila) |
chr7_+_37723336 | 1.35 |
ENST00000450180.1
|
GPR141
|
G protein-coupled receptor 141 |
chr19_+_23945768 | 1.34 |
ENST00000486528.1
ENST00000496398.1 |
RPSAP58
|
ribosomal protein SA pseudogene 58 |
chr22_+_23161491 | 1.34 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
chr17_+_41150479 | 1.34 |
ENST00000589913.1
|
RPL27
|
ribosomal protein L27 |
chr21_+_10862622 | 1.33 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
chr18_-_67624160 | 1.33 |
ENST00000581982.1
ENST00000280200.4 |
CD226
|
CD226 molecule |
chrX_-_15332665 | 1.32 |
ENST00000537676.1
ENST00000344384.4 |
ASB11
|
ankyrin repeat and SOCS box containing 11 |
chr1_-_160492994 | 1.32 |
ENST00000368055.1
ENST00000368057.3 ENST00000368059.3 |
SLAMF6
|
SLAM family member 6 |
chr1_-_205091115 | 1.32 |
ENST00000264515.6
ENST00000367164.1 |
RBBP5
|
retinoblastoma binding protein 5 |
chr8_-_133772870 | 1.32 |
ENST00000522334.1
ENST00000519016.1 |
TMEM71
|
transmembrane protein 71 |
chr14_+_100532771 | 1.31 |
ENST00000557153.1
|
EVL
|
Enah/Vasp-like |
chr12_-_10151773 | 1.31 |
ENST00000298527.6
ENST00000348658.4 |
CLEC1B
|
C-type lectin domain family 1, member B |
chr19_+_50016411 | 1.30 |
ENST00000426395.3
ENST00000600273.1 ENST00000599988.1 |
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
chr7_-_36764004 | 1.29 |
ENST00000431169.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
chr17_+_41150290 | 1.28 |
ENST00000589037.1
ENST00000253788.5 |
RPL27
|
ribosomal protein L27 |
chr18_-_47018869 | 1.28 |
ENST00000583036.1
ENST00000580261.1 |
RPL17
|
ribosomal protein L17 |
chr15_-_50558223 | 1.28 |
ENST00000267845.3
|
HDC
|
histidine decarboxylase |
chr1_+_225600404 | 1.26 |
ENST00000366845.2
|
AC092811.1
|
AC092811.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
1.1 | 5.5 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
1.1 | 1.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.0 | 4.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.9 | 3.7 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.9 | 2.7 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.9 | 4.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.9 | 2.6 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.7 | 2.1 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.7 | 118.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.7 | 6.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.7 | 3.9 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.6 | 3.7 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.6 | 2.5 | GO:1902523 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.6 | 1.7 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.6 | 2.8 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.5 | 3.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 2.5 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.5 | 4.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 2.1 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
0.4 | 2.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.4 | 1.2 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.4 | 2.7 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.4 | 1.2 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.4 | 1.9 | GO:0039513 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.4 | 2.6 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.4 | 0.4 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
0.4 | 0.7 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.4 | 8.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.4 | 5.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 1.8 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.3 | 0.7 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 2.0 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.3 | 1.0 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 1.6 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.3 | 1.0 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.3 | 0.6 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.3 | 1.2 | GO:0035548 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
0.3 | 2.2 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.3 | 61.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.3 | 2.6 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.3 | 1.1 | GO:0035690 | cellular response to drug(GO:0035690) |
0.3 | 0.6 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.3 | 1.4 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.3 | 0.8 | GO:1990637 | response to prolactin(GO:1990637) |
0.3 | 1.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 1.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.2 | 1.7 | GO:0048241 | epinephrine transport(GO:0048241) |
0.2 | 1.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.5 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.2 | 0.9 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 1.1 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.2 | 0.7 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
0.2 | 6.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 1.1 | GO:0032796 | uropod organization(GO:0032796) |
0.2 | 0.7 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.2 | 0.7 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.2 | 0.7 | GO:0060345 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.2 | 0.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 0.6 | GO:1902960 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) regulation of neurofibrillary tangle assembly(GO:1902996) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.2 | 0.9 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.2 | 1.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 0.6 | GO:0031247 | actin rod assembly(GO:0031247) |
0.2 | 5.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.2 | 2.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 0.8 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.2 | 0.6 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.2 | 1.4 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.2 | 3.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.6 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.6 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.2 | 1.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.5 | GO:0021934 | medulla oblongata development(GO:0021550) hindbrain tangential cell migration(GO:0021934) lateral line system development(GO:0048925) |
0.2 | 0.7 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.2 | 3.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 2.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 0.8 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.2 | 1.0 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.2 | 7.6 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.6 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.2 | 1.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 1.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.4 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 0.6 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.1 | 3.8 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 2.3 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.1 | 2.1 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 2.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 1.1 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 1.1 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.1 | 3.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.7 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.5 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.1 | 0.6 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.1 | 0.4 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.1 | 0.5 | GO:2001301 | cellular response to interleukin-13(GO:0035963) lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.1 | 8.8 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 1.8 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.5 | GO:0060928 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
0.1 | 0.6 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.4 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.5 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.5 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.3 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.1 | 0.7 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 1.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.5 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.3 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.1 | 0.8 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.1 | 0.4 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.4 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.1 | 2.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 1.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.4 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
0.1 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.2 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 1.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.6 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.1 | 1.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.8 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.7 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.7 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 1.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.1 | 2.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 1.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 1.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.3 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 1.7 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.6 | GO:0045471 | response to ethanol(GO:0045471) |
0.1 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 1.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.4 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.1 | 0.5 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.1 | 1.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 5.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.4 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.8 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.1 | 0.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.8 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 0.5 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.5 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 2.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 1.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.1 | 1.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.8 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.6 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 1.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.5 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.1 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 1.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 1.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.7 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 1.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.3 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 1.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 1.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.3 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.6 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 1.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 2.4 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.2 | GO:0042000 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
0.1 | 0.3 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 0.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.3 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.1 | 0.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 2.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.3 | GO:0043382 | interleukin-23-mediated signaling pathway(GO:0038155) positive regulation of memory T cell differentiation(GO:0043382) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.1 | 0.2 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.1 | 0.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.9 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.1 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 0.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.8 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.2 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.0 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.0 | 0.1 | GO:0039022 | pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) Kupffer's vesicle development(GO:0070121) |
0.0 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.3 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 7.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 2.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.5 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 1.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.9 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.4 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.2 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.0 | 0.3 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 1.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.4 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.0 | 1.0 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 1.2 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.3 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.5 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.0 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 13.1 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 1.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.0 | 0.2 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.0 | 0.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 1.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.1 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.0 | 0.2 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.0 | 0.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.5 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.3 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 3.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 4.1 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.5 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.0 | 0.2 | GO:0034959 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.5 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.5 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.8 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.1 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.4 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.5 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.4 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.1 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.0 | 0.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.2 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.4 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.2 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.0 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 1.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.7 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.7 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.3 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.1 | GO:0015692 | lead ion transport(GO:0015692) |
0.0 | 0.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.4 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.2 | GO:0060844 | arterial endothelial cell fate commitment(GO:0060844) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.0 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.7 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.0 | 0.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.4 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.0 | 0.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.0 | 1.9 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:0098789 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 2.1 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.1 | GO:0061582 | colon epithelial cell migration(GO:0061580) intestinal epithelial cell migration(GO:0061582) |
0.0 | 2.0 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 3.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.5 | GO:0030323 | respiratory tube development(GO:0030323) |
0.0 | 0.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 1.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.3 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.8 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.0 | 0.1 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.0 | 0.3 | GO:0046638 | positive regulation of alpha-beta T cell differentiation(GO:0046638) |
0.0 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.0 | GO:0032402 | melanosome transport(GO:0032402) |
0.0 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.8 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.5 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.0 | 2.1 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.0 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 1.0 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.2 | GO:0015866 | ADP transport(GO:0015866) |
0.0 | 0.3 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.0 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.7 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.3 | GO:1904590 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
0.0 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.1 | GO:0042113 | B cell activation(GO:0042113) |
0.0 | 0.1 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.1 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.3 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 9.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 2.6 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.5 | 25.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.4 | 3.6 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.4 | 1.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 2.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.3 | 3.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 9.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.9 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 1.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 1.1 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.2 | 1.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 4.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.6 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.2 | 1.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.2 | 0.6 | GO:0043614 | multi-eIF complex(GO:0043614) translation preinitiation complex(GO:0070993) glial limiting end-foot(GO:0097451) |
0.2 | 1.1 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.2 | 0.7 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.2 | 34.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 1.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 2.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 2.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 4.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 2.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.0 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 8.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 2.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 2.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.1 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.4 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.1 | 1.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 1.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 5.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.7 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.8 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 1.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.8 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.4 | GO:0097196 | Shu complex(GO:0097196) |
0.1 | 0.3 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.1 | 1.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 0.7 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.1 | 0.6 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 0.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.5 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 2.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.2 | GO:0005715 | late recombination nodule(GO:0005715) |
0.1 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 1.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.9 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 1.0 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.2 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 4.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 1.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.7 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 2.1 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 1.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
0.0 | 1.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 5.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.0 | 15.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 3.6 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 1.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.5 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.0 | 0.6 | GO:0098553 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.0 | 3.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.6 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 1.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.8 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 1.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 2.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.6 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.5 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.0 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.3 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.0 | 0.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 2.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 5.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.4 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 2.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 2.9 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 3.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 40.6 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 0.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 1.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.7 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) cytoplasmic side of lysosomal membrane(GO:0098574) |
0.0 | 1.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 5.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0031592 | centrosomal corona(GO:0031592) |
0.0 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.2 | GO:0030018 | Z disc(GO:0030018) I band(GO:0031674) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.2 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
1.1 | 3.2 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.8 | 2.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.8 | 2.4 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.8 | 3.9 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.7 | 4.5 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.6 | 171.0 | GO:0003823 | antigen binding(GO:0003823) |
0.6 | 1.7 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.4 | 2.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 1.7 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
0.4 | 1.2 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.4 | 2.8 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.4 | 2.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 1.9 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.4 | 9.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 1.8 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.3 | 1.0 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.3 | 1.0 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.3 | 1.8 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.3 | 2.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.3 | 1.4 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.2 | 1.2 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.2 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.5 | GO:0046977 | peptide antigen-transporting ATPase activity(GO:0015433) TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.2 | 7.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 5.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.9 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 6.4 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.7 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.2 | 0.7 | GO:0097689 | iron channel activity(GO:0097689) |
0.2 | 0.6 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.2 | 6.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 2.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 1.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 1.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 1.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.2 | 1.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 4.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.6 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.2 | 1.2 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 2.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 1.0 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.2 | 0.8 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.2 | 0.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 1.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.6 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 2.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.5 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.2 | 0.6 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 2.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 6.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.0 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 1.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.6 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.1 | 1.1 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.8 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 0.5 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.5 | GO:0050473 | hepoxilin-epoxide hydrolase activity(GO:0047977) arachidonate 15-lipoxygenase activity(GO:0050473) |
0.1 | 0.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.5 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.1 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 1.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.5 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 1.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 1.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 4.6 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.3 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.1 | 2.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 1.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.4 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
0.1 | 0.2 | GO:0017129 | triglyceride binding(GO:0017129) |
0.1 | 2.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.6 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.5 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 1.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 1.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.3 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.1 | 0.4 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.5 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 1.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 1.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.7 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 0.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.8 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 2.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 2.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.7 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 0.3 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 0.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.4 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 1.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 1.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.3 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.2 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.1 | 0.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 0.2 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.1 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.2 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.1 | 0.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 5.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 2.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 2.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.0 | 0.7 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 1.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 2.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 1.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 2.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 1.0 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 2.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 3.6 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.2 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.0 | 1.9 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.6 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 1.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 1.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 1.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 3.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 1.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.7 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
0.0 | 0.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 1.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 1.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 2.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 1.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 1.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 1.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 1.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.2 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 1.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 4.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 8.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.0 | 0.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 1.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 1.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 1.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.2 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.0 | 0.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.0 | 0.1 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.0 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.2 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.1 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 3.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 6.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.3 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 1.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.0 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 1.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 3.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 1.2 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.4 | GO:0004871 | signal transducer activity(GO:0004871) |
0.0 | 0.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 1.0 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.1 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 4.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.2 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 1.2 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 8.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 5.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 4.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 4.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 1.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 2.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 3.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 2.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 2.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 3.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 1.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 2.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 2.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 2.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 8.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 1.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 3.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 16.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 4.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 6.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 6.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 10.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 3.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 13.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 2.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 2.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 3.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 3.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 1.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 5.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 15.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 5.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 4.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 1.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.8 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 4.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 3.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.8 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 1.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.9 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 4.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 1.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 1.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 1.1 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.5 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 1.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |